• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS, INC. ATELLICA IM HIGH-SENSITIVITY TROPONIN I (TNIH)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS, INC. ATELLICA IM HIGH-SENSITIVITY TROPONIN I (TNIH) Back to Search Results
Model Number N/A
Device Problem Low Test Results (2458)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/18/2021
Event Type  malfunction  
Manufacturer Narrative
A customer from outside the united states observed an atellica im high-sensitivity troponin i (tnih) result that was below the 99th%tile of 45.2 pg/ml (ng/l) for the atellica im tnih assay but the result was above the 99th%tile of 14 ng/l for troponin t from an alternate method.Siemens is investigating.The interpretation of results section of the instructions for use states: "results of this assay should always be interpreted in conjunction with patient's medical history, clinical presentation and other findings.".
 
Event Description
The customer observed an atellica im high-sensitivity troponin i (tnih) result that was below the 99th%tile of 45.2 pg/ml (ng/l) for the atellica im tnih assay but the result was above the 99th%tile of 14 ng/l for troponin t from an alternate method.The result was reported to the physician(s).There are no reports that treatment was altered or prescribed or adverse health consequences due to the atellica im tnih result.
 
Manufacturer Narrative
Initial mdr 1219913-2021-00519 was reported on 23 dec 2021.Additional information received on 28 dec 2021: an outside us customer observed depressed atellica im tnih results on a patient sample vs alternate method results above the cutoff of 14 ng/l.Siemens reviewed the available information to determine probable cause and evaluate for potential product issue.Qc in range which indicates this is patient/sample specific incident.The escalation contains data from 22 patient samples run from (b)(6) 2019 to (b)(6) 2021.Samples were run on atellica im tnih and in some cases alternate method.One sample (patient 16) gave a atellica im tnih result < instructions for use (ifu) reference cutoff of 45 ng/l vs alternate method result >14 ng/l.The alternate method is a troponin t method vs the atellica im tnih which is a troponin i method; there is no claim that results will match between tests due to differences in antibodies/epitopes being measured.The limitations section of the ifu states: "patient samples may contain heterophilic antibodies that could react in immunoassays to give falsely elevated or depressed results.The atellica im tnih assay is designed to minimize interference from heterophilic antibodies." however patient samples may contain heterophilic antibodies and/or other interferences such as immune complexes (macro tni) that could react in immunoassays to give falsely elevated or depressed results.The interpretation of results section of the ifu states: "results of this assay should always be interpreted in conjunction with the patient's medical history, clinical presentation, and other findings." no potential product issue is observed.The customer is operational.No further action is needed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ATELLICA IM HIGH-SENSITIVITY TROPONIN I (TNIH)
Type of Device
TROPONIN I
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
511 benedict avenue
tarrytown NY 10591 5097
Manufacturer (Section G)
SIEMENS HEALTHCARE DIAGNOSTICS, INC
333 coney street
east walpole MA 02032
Manufacturer Contact
louise mclaughlin
333 coney street
east walpole, MA 02032
7818564812
MDR Report Key13080343
MDR Text Key289337712
Report Number1219913-2021-00519
Device Sequence Number1
Product Code MMI
UDI-Device Identifier00630414006703
UDI-Public00630414006703
Combination Product (y/n)N
Reporter Country CodeNL
PMA/PMN Number
K171566
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 01/24/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberN/A
Device Catalogue Number10997840
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/06/2021
Initial Date FDA Received12/23/2021
Supplement Dates Manufacturer Received12/28/2021
Supplement Dates FDA Received01/24/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-